There is a number your finance team knows very precisely, and a number they almost certainly don't know at all.
The first is your annual healthcare premium spend. It's in the budget, reconciled quarterly, tracked against prior years. For a 2,000-employee organisation in Southeast Asia, it might be as high as $600,000.
The second number is what poor employee health actually costs your business—not in insurance premiums, but in lost productivity, preventable absenteeism, and the attrition of people whose health deteriorated faster than your wellness strategy could respond. That number, for the same 2,000-employee organisation, is likely to be in the region of $4 million. It doesn't appear anywhere on a P&L. Nobody reconciles it quarterly. In most organisations, it has never been calculated at all.
This is not a healthcare cost problem. It's a measurement problem.
The Costs Hiding Outside Your Claims Data
Traditional healthcare cost analysis looks at what's directly visible: premiums, claims, and out-of-pocket expenses. This captures roughly a fifth of the real economic burden. The rest—the vastly larger portion—lives in productivity losses that never make it into a dashboard.
Presenteeism is the most significant and least discussed of these. An employee with untreated anxiety or depression who shows up every day costs more than an employee who takes a sick day. They're present but operating at a fraction of their capacity—making slower decisions, missing things, disengaging from the collaboration that drives output. Research published in Social Psychiatry and Psychiatric Epidemiology consistently shows that presenteeism costs are five to ten times higher than absenteeism. In Singapore alone, untreated depression and anxiety contribute an estimated SGD $15.7 billion annually through absenteeism, presenteeism, and healthcare expenses, according to research published in BMC Psychiatry.
The medical inflation trajectory adds further urgency. According to WTW's 2026 Global Medical Trends Survey, healthcare inflation in Asia Pacific is projected to reach 14%—the third consecutive year of double-digit increases. In Malaysia,Bank Negara reported that 60% of health insurance policies experienced premium hikes of up to 20%, with 30% seeing hikes between 21–40%. At that rate, a $2 million premium spend today becomes $3.4 million in three years without any change to your workforce's underlying health trajectory.
The ROI Case Is Clear—Once You Know Where to Look
The McKinsey Health Institute estimates that for a middle-income economy—the profile that describes much of Southeast Asia—investing in worker health can recover $1,000 to $3,000 per employee annually. That breaks down as 9.6% of payroll value through reduced presenteeism, 2.8% through lower absenteeism, and 4.6% through improved retention. Across a 2,000-person workforce, that's a potential productivity recovery running into the millions—from an investment most organisations still treat as a discretionary benefit.
A Deloitte study in the UK found that every £1 spent on mental health returned £5 in business value. While the cultural and structural context differs across Southeast Asia, the underlying economics are comparable—and the lower baseline of support infrastructure in the region arguably means the upside is greater, not smaller.
Naluri's own analysis of benchmarked claims data puts numbers on what intervention achieves in practice. Employees with chronic diseases who engaged with primary care and preventive health services saw total annual claims fall by 56%. Inpatient claims fell by 34%, while specialist claims fell by 43%. These are outcomes observed in real populations, not projections from a theoretical model.
Making Wellness a Finance Conversation, Not Just an HR One
Wellness and mental health investment rarely reaches the CFO's desk as a strategic conversation. It tends to arrive as a line item in the HR budget, evaluated against other HR line items, approved or trimmed based on how the quarter looks.
The organisations treating it differently—as a margin protection strategy, a medical inflation hedge, and a productivity investment rather than a cost of compliance—are finding that it changes both the budget conversation and the outcome. The American Psychological Association's Work and Well-being Survey found that 81% of workers would actively prioritise employers that support mental health when seeking future roles. In competitive talent markets like Singapore, Malaysia, and increasingly Indonesia and Vietnam, that preference has real commercial consequences for hiring costs, offer acceptance rates, and the quality of candidates who choose you over a competitor.
The Framing Shift That Changes Everything
Employee wellness has historically been positioned as a people issue with a people budget. The organisations leading on this are repositioning it as a financial issue with a measurable return—and finding that it holds up to scrutiny far better than most other investments competing for the same capital.
When you account for the full picture—rising claims costs, the productivity burden of presenteeism, turnover driven by poor health, and a medical inflation rate that doubles direct costs every five years without intervention—the economics are not ambiguous. The question is not whether investing in employee health delivers a return. It does, consistently and substantially. The question is whether your organisation is measuring enough of the cost of inaction to feel the urgency that the numbers justify.
If your organisation is carrying a $600,000 premium spend alongside a $4 million productivity burden you've never formally counted, the relevant question isn't whether you can afford to invest in employee health. It's whether you can afford to keep not measuring the full cost of what's already happening.
For more on the financial case for employee wellness in Southeast Asia, read our white paper The New Economics of Workplace Wellness in Southeast Asia or talk to our sales team.